What should be described when defining response variables?

• A. The observation methods and how measurements will be quantified.
• B. The patient satisfaction metrics only.
• C. The final p-values to be achieved.
• D. How to manipulate data to show significance.

Answer: (A)

Describing how you will observe and quantify the outcome variable is essential because the response variable is the measurable effect you’re aiming to detect. You need to specify the observation methods (what exact data will be collected, who collects it, and with what instruments or procedures) and how measurements will be quantified (the scale or units, scoring rules, timing, and any data processing steps). This predefines what counts as a response and ensures consistency across participants and sites, enabling valid statistical analysis and comparison. In clinical trials under GCP, this aligns with pre-specified endpoints documented in the protocol and case report forms, ideally using validated measurement tools. Focusing only on a single metric like patient satisfaction and not detailing how it will be observed and quantified leaves the outcome undefined; final p-values pertain to analysis results, not to defining the variable; and planning to manipulate data to show significance is unethical and not part of proper trial design.